Key result
CD8-specific PD-1 knockout worsens overload-induced cardiac inflammation and dysfunction.
Why the study?
The underlying mechanism of PD-1 in systolic overload-induced cardiac inflammation is incompletely understood.
Intracellular PD-1 in CD8+ T cells, but not Tregs, plays a critical role in modulating systolic overload-induced cardiac inflammation and dysfunction via the CXCR3 pathway.
Answers are grounded in this paper and cite their sources.
May differentially modulate overload-induced cardiac inflammation via T-cell subsets; leaves open targeted mechanistic validation before therapeutic translation.
Both CD8+ T cells and anti-inflammatory Tregs exert important roles in modulating systolic overload-induced cardiac inflammation, and immune checkpoint inhibitor PD-1 regulating CD8+ T cells, Tregs, and other type cells. However, the underlying mechanism of PD-1 in systolic overload-induced cardiac inflammation is still incompletely understood. To test the hypothesis that intracellular PD-1 of different type T cell subset exerts distinct role in regulating cardiac inflammation and heart failure (HF) development, we investigated the effects of global PD-1 knockout, pharmacological PD-1 antibody, CD8 cell specific PD-1 KO, and Treg specific PD-1 knockout (KO) on systolic overload-induced cardiac inflammation, cardiac accumulation of different immune cell types, cardiac fibrosis, hypertrophy, and HF development in mice. While systolic and cell specific PD-1 inhibition had no detectable effect on cardiac inflammation and function under control conditions, PD-1 KO and PD-1 blocking antibody significantly exacerbated Transverse Aortic Constriction (TAC)-induced cardiac accumulation of various immune cell subsets, including CD8 T cells, Tregs, and macrophages, which were dynamically changed after TAC. In addition, depletion of CD8 T cells or macrophages were effectively attenuated TAC-induced cardiac inflammation and dysfunction in PD-1 KO mice. Single cell RNA-seq showed that the genetic profiles of multiple cardiac T cell subset were drastically changed in PD-1 KO mice after TAC, while bulk RNA-seq showed that PD-1 KO drastically changed the cardiac gene profiles in mice after TAC. Moreover, by using CD8 cell specific and Treg specific PD-1 deficient mouse strains, we further demonstrated that intracellular PD-1 in CD8 T cells but not in Tregs exert the critical role in modulating TAC-induced cardiac inflammation and dysfunction. Mechanistically, we found that CD8 cell specific PD-1 KO significantly increased CD8+ T cells’ intracellular production IFNg and surface expression of chemokine receptors such as CXCR3 in hearts, lungs, and drainage lymph nodes in mice under control conditions. Above changes were drastically increased in CD8 cell specific PD-1 KO mice after TAC, indicating that PD1 expressed inside CD8+ T cells play and important role in shaping cardiac CD8 T cells’ multiple functional capacities and inflammation. Furthermore, we found that CXCL9 and CXCL10, two known ligands of CXCR3, are increased in cardiac macrophages in PD-1 KO mice, while CXCR3 antibody or inhibition of cardiac CXCR9 and CXCR10 was effective in attenuating TAC-induced cardiac accumulation CD8+ T cells, inflammation, fibrosis, and cardiac dysfunction. Collectively, our findings demonstrates that macrophages and CD8+ T cells, the crosstalk by macrophages and CD8+ T cells, and intracellular PD-1 in CD8+ T cells play important roles in systolic overload-induced cardiac inflammation and dysfunction. Funding source: This work was supported by research grants R01HL161085, R01HL139797, P20GM104357, and P30GM149404 from NIH; and a postdoctoral fellowship 23POST1029902 from American Heart Association. This abstract was presented at the American Physiology Summit 2026 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied Systolic overload-induced cardiac inflammation and heart failure. PD-1 knockout (global, CD8-specific, Treg-specific) or PD-1 blocking antibody vs. Control conditions was evaluated on Cardiac inflammation, fibrosis, hypertrophy, and heart failure development. CD8 cell-specific PD-1 knockout exacerbated systolic overload-induced cardiac inflammation and dysfunction, demonstrating a critical role for intracellular PD-1 in CD8+ T cells.
Synapse has enriched 10 related papers. Consider them for comparative context: